| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |